|
EP0054540A1
(en)
|
1980-04-07 |
1982-06-30 |
BERMAN Joel d/b/a JOEL BERMAN ASSOCIATES |
Window shade roller assembly
|
|
US4816567A
(en)
*
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
EP0381296B1
(en)
|
1984-04-30 |
1994-11-30 |
THE PROCTER & GAMBLE COMPANY |
Kit for use in the treatment of osteoporosis
|
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
|
US4631211A
(en)
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
|
US5618920A
(en)
*
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
US5225539A
(en)
*
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5324819A
(en)
|
1988-04-08 |
1994-06-28 |
Stryker Corporation |
Osteogenic proteins
|
|
US5266683A
(en)
*
|
1988-04-08 |
1993-11-30 |
Stryker Corporation |
Osteogenic proteins
|
|
US5344654A
(en)
*
|
1988-04-08 |
1994-09-06 |
Stryker Corporation |
Prosthetic devices having enhanced osteogenic properties
|
|
US5010175A
(en)
*
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
|
US5298852A
(en)
|
1988-12-22 |
1994-03-29 |
Robert Bosch Gmbh |
Arrangement for and method of controlling a three-phase-generator in a vehicle
|
|
US5530101A
(en)
*
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5561173A
(en)
*
|
1990-06-19 |
1996-10-01 |
Carolyn M. Dry |
Self-repairing, reinforced matrix materials
|
|
CA2082160C
(en)
*
|
1991-03-06 |
2003-05-06 |
Mary M. Bendig |
Humanised and chimeric monoclonal antibodies
|
|
US5656593A
(en)
|
1991-03-11 |
1997-08-12 |
Creative Biomolecules, Inc. |
Morphogen induced periodontal tissue regeneration
|
|
US5118667A
(en)
|
1991-05-03 |
1992-06-02 |
Celtrix Pharmaceuticals, Inc. |
Bone growth factors and inhibitors of bone resorption for promoting bone formation
|
|
AU669124B2
(en)
*
|
1991-09-18 |
1996-05-30 |
Kyowa Hakko Kirin Co., Ltd. |
Process for producing humanized chimera antibody
|
|
US5565332A
(en)
*
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
WO1993009229A1
(en)
*
|
1991-11-04 |
1993-05-13 |
Genetics Institute, Inc. |
Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
|
|
GB9125979D0
(en)
|
1991-12-06 |
1992-02-05 |
Wellcome Found |
Antibody
|
|
CA2130436C
(en)
|
1992-02-19 |
2001-04-10 |
John S. Abrams |
Cloning and expression of humanized monoclonal antibodies against human interleukin-4
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
US5639641A
(en)
*
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
IT1255522B
(it)
|
1992-09-24 |
1995-11-09 |
Ubaldo Conte |
Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
|
|
AU671721B2
(en)
*
|
1993-01-12 |
1996-09-05 |
Genentech Inc. |
Tgf-beta formulation for inducing bone growth
|
|
TW303299B
(https=)
*
|
1993-07-22 |
1997-04-21 |
Lilly Co Eli |
|
|
US5705154A
(en)
*
|
1995-03-08 |
1998-01-06 |
Schering Corporation |
Humanized monoclonal antibodies against human interleukin-4
|
|
US5550134A
(en)
*
|
1995-05-10 |
1996-08-27 |
Eli Lilly And Company |
Methods for inhibiting bone loss
|
|
DE19647853A1
(de)
*
|
1996-11-19 |
1998-05-20 |
Bioph Biotech Entw Pharm Gmbh |
Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität
|
|
US5939039A
(en)
|
1997-01-16 |
1999-08-17 |
Orthovita, Inc. |
Methods for production of calcium phosphate
|
|
JP4388602B2
(ja)
*
|
1997-02-07 |
2009-12-24 |
ストライカー コーポレイション |
マトリクスを含まない骨形成デバイス、移植片、およびその使用方法
|
|
US20020098222A1
(en)
*
|
1997-03-13 |
2002-07-25 |
John F. Wironen |
Bone paste
|
|
US7041641B2
(en)
*
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
|
ATE250434T1
(de)
*
|
1997-04-22 |
2003-10-15 |
Washington Res Found |
Knochentransplantate und -prothesen beschichtet mit tartratbeständiger säurephosphatase
|
|
US6025538A
(en)
*
|
1998-11-20 |
2000-02-15 |
Musculoskeletal Transplant Foundation |
Compound bone structure fabricated from allograft tissue
|
|
ATE481487T1
(de)
|
1998-11-27 |
2010-10-15 |
Ucb Sa |
Zusammensetzungen und verfahren zur erhöhung der knochenmineralisierung
|
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
|
US6756480B2
(en)
*
|
2000-04-27 |
2004-06-29 |
Amgen Inc. |
Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
|
|
US20030082233A1
(en)
*
|
2000-12-01 |
2003-05-01 |
Lyons Karen M. |
Method and composition for modulating bone growth
|
|
US20020169122A1
(en)
|
2001-02-23 |
2002-11-14 |
Wyeth |
Chondrogenic potential of human bone marrow-derived CD105+ cells by BMP
|
|
US6949251B2
(en)
|
2001-03-02 |
2005-09-27 |
Stryker Corporation |
Porous β-tricalcium phosphate granules for regeneration of bone tissue
|
|
WO2002092000A2
(en)
|
2001-05-11 |
2002-11-21 |
Genome Therapeutics Corporation |
Hbm variants that modulate bone mass and lipid levels
|
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
|
EP2295081B1
(en)
*
|
2001-06-26 |
2018-10-31 |
Amgen Inc. |
Antibodies to OPGL
|
|
WO2003070288A2
(en)
*
|
2001-10-12 |
2003-08-28 |
Inframat Corporation |
Coated implants and methods of coating implants
|
|
US20040235728A1
(en)
|
2001-11-08 |
2004-11-25 |
Stoch Selwyn Aubrey |
Compositions and methods for treating osteoporosis
|
|
EP1531855A4
(en)
*
|
2002-01-10 |
2009-07-22 |
Osteotrophin Llc |
TREATMENT OF BONE DISEASES WITH SKELETTAL ANABOLIKA
|
|
JP2005519067A
(ja)
*
|
2002-01-17 |
2005-06-30 |
ザ ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
トロンビンペプチド誘導体を用いた骨成長および軟骨形成の刺激
|
|
JP3646167B2
(ja)
*
|
2002-02-19 |
2005-05-11 |
独立行政法人産業技術総合研究所 |
フォスフォフォリンを含む複合生体材料
|
|
AU2003223214B2
(en)
*
|
2002-03-01 |
2008-09-18 |
Celltech R & D, Inc. |
Methods to increase or decrease bone density
|
|
US7166133B2
(en)
*
|
2002-06-13 |
2007-01-23 |
Kensey Nash Corporation |
Devices and methods for treating defects in the tissue of a living being
|
|
US7585501B2
(en)
|
2002-06-14 |
2009-09-08 |
Stowers Institute For Medical Research |
Compositions and methods for treating kidney disease
|
|
US7893218B2
(en)
|
2003-06-16 |
2011-02-22 |
Stowers Institute For Medical Research |
Antibodies that specifically bind SOST peptides
|
|
US20040023356A1
(en)
|
2002-06-14 |
2004-02-05 |
Robb Krumlauf |
Wise/Sost nucleic acid sequences and amino acid sequences
|
|
US20040002770A1
(en)
|
2002-06-28 |
2004-01-01 |
King Richard S. |
Polymer-bioceramic composite for orthopaedic applications and method of manufacture thereof
|
|
JP2005532395A
(ja)
*
|
2002-07-02 |
2005-10-27 |
スミスクライン・ビーチャム・コーポレイション |
新規な安定処方
|
|
US20040023322A1
(en)
*
|
2002-08-01 |
2004-02-05 |
Goodheart Clyde R. |
Method of producing non-recombinant BMP-2 and use thereof
|
|
KR20040023356A
(ko)
|
2002-09-11 |
2004-03-18 |
현대모비스 주식회사 |
파킹브레이크 작동시 출발제한 시스템 및 그 방법
|
|
JP2006503615A
(ja)
|
2002-09-30 |
2006-02-02 |
リージェン バイオテック インコーポレーテッド |
硫酸カルシウム及び粘性を有するポリマーを含む骨形成および骨硬化を促進させる骨充填用組成物
|
|
JP3851602B2
(ja)
*
|
2002-10-02 |
2006-11-29 |
ペンタックス株式会社 |
骨形成治療デバイス
|
|
JP2007525953A
(ja)
|
2003-06-06 |
2007-09-13 |
ワイス |
骨リモデリングを調節する物質を同定するための方法および材料、ならびにそれによって同定された物質
|
|
CA2529623A1
(en)
|
2003-06-16 |
2005-02-17 |
Celltech R & D, Inc. |
Antibodies specific for sclerostin and methods for increasing bone mineralization
|
|
US7943393B2
(en)
|
2003-07-14 |
2011-05-17 |
Phynexus, Inc. |
Method and device for extracting an analyte
|
|
US6976816B2
(en)
|
2003-08-01 |
2005-12-20 |
Dana Corporation |
Combination lock washer and spindle bearing assembly
|
|
MY141763A
(en)
*
|
2003-09-18 |
2010-06-30 |
Novartis Ag |
Pharmaceutical products comprising bisphosphonates
|
|
US8461155B2
(en)
|
2003-09-22 |
2013-06-11 |
University Of Connecticut |
Sclerostin and the inhibition of WNT signaling and bone formation
|
|
US8895540B2
(en)
*
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
|
WO2005070439A1
(en)
*
|
2004-01-09 |
2005-08-04 |
Regeneration Technologies Inc. |
Implant comprising a human muscle tissue matrix
|
|
US7189263B2
(en)
|
2004-02-03 |
2007-03-13 |
Vita Special Purpose Corporation |
Biocompatible bone graft material
|
|
US7531518B2
(en)
*
|
2004-05-14 |
2009-05-12 |
Unigene Laboratories Inc. |
Method for fostering bone formation and preservation
|
|
US7648965B2
(en)
*
|
2004-05-14 |
2010-01-19 |
Unigene Laboratories Inc. |
Method for fostering bone formation and preservation
|
|
AU2005250441A1
(en)
*
|
2004-05-27 |
2005-12-15 |
Acceleron Pharma Inc. |
TGF derepressors and uses related thereto
|
|
WO2006015373A2
(en)
|
2004-08-04 |
2006-02-09 |
Amgen Inc |
Antibodies to dkk-1
|
|
JP2008517660A
(ja)
*
|
2004-10-22 |
2008-05-29 |
ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ |
生物剤を送達する中空かつ多孔質の整形外科用または歯科用のインプラント
|
|
MX2007008319A
(es)
*
|
2005-01-06 |
2007-10-04 |
Kuros Biosurgery Ag |
Matrices suplementadas para la reparacion de fracturas oseas.
|
|
US7531533B2
(en)
*
|
2005-01-27 |
2009-05-12 |
Asahi Kasei Pharma Corporation |
6-Membered heterocyclic compound and use thereof
|
|
US8071574B2
(en)
|
2005-02-22 |
2011-12-06 |
John Dennis Bobyn |
Implant improving local bone formation
|
|
US20060198863A1
(en)
|
2005-03-03 |
2006-09-07 |
Musculoskeletal Transplant Foundation |
Ceramic composition for filling bone defects
|
|
US7592429B2
(en)
*
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
|
US8003108B2
(en)
*
|
2005-05-03 |
2011-08-23 |
Amgen Inc. |
Sclerostin epitopes
|
|
JP2006320442A
(ja)
|
2005-05-18 |
2006-11-30 |
Toshiba Ceramics Co Ltd |
リン酸カルシウム系骨補填材
|
|
US20060293667A1
(en)
*
|
2005-05-19 |
2006-12-28 |
Agnes Vignery |
Bone implant device and methods of using same
|
|
WO2006135734A2
(en)
|
2005-06-10 |
2006-12-21 |
The Regents Of The University Of California |
Compositions and methods for altering bone density and bone patterning
|
|
NZ564098A
(en)
*
|
2005-06-15 |
2010-04-30 |
Schering Corp |
Anti-IGF1R antibody formulations
|
|
CN103349793B
(zh)
|
2005-09-09 |
2016-02-10 |
阿格诺沃斯健康关爱公司 |
复合骨移植替代物水泥以及由其制得的制品
|
|
KR20080084808A
(ko)
|
2005-11-17 |
2008-09-19 |
바이오미메틱 세라퓨틱스, 인크. |
ｒｈＰＤＧＦ-ＢＢ 및 생체적합성 매트릭스를 사용하는상악안면골 보강
|
|
US8158828B2
(en)
*
|
2005-11-28 |
2012-04-17 |
Gtx, Inc. |
Nuclear receptor binding agents
|
|
BRPI0620316A2
(pt)
|
2005-12-21 |
2011-11-08 |
Wyeth Corp |
formulações de proteìnas com viscosidades reduzida e seus usos
|
|
EP2460828A3
(en)
|
2006-11-10 |
2012-08-08 |
UCB Pharma, S.A. |
Antibodies and diagnostics
|
|
EP3345607B1
(en)
*
|
2006-12-29 |
2022-10-26 |
Ossifi-Mab LLC |
Methods of altering bone growth by administration of sost or wise antagonist or agonist
|
|
MY149129A
(en)
|
2007-03-20 |
2013-07-15 |
Lilly Co Eli |
Anti-sclerostin antibodies
|
|
WO2008133618A1
(en)
|
2007-04-27 |
2008-11-06 |
Unigene Laboratories, Inc. |
Methods and compositions for fostering and preserving bone growth
|
|
CL2008002775A1
(es)
|
2007-09-17 |
2008-11-07 |
Amgen Inc |
Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
|
|
TWI489993B
(zh)
*
|
2007-10-12 |
2015-07-01 |
Novartis Ag |
骨硬化素（ｓｃｌｅｒｏｓｔｉｎ）抗體組合物及使用方法
|
|
TWI452136B
(zh)
*
|
2010-11-17 |
2014-09-11 |
中外製藥股份有限公司 |
A multiple specific antigen-binding molecule that replaces the function of Factor VIII in blood coagulation
|
|
US8790651B2
(en)
*
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
JP6511233B2
(ja)
|
2014-08-28 |
2019-05-15 |
株式会社竹中工務店 |
柱脚部と鉄骨梁との接合構造
|